A co-expression of glioma biomarkers (GFAP, IDH1R132H, and PDGFRA) and macrophage biomarkers (CD68 and CD14) is also noticed on some cells, defined as GAM-GBM hybrid cells. This evidence concerns the gene CD68 and central nervous system cancer.